OSL · MEDI.OL
Medistim ASA
NOK 310.00+NOK 3.00 (+0.98%)
Medistim ASA’s quoted price sits in the upper half of its reported 52-week range, 1.9% below the high.
Loading market information…
OSL · OMDA.OL · NOK
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 02:58 PM UTC. Cached market data; not a live quote.
One-year closing-price history · NOK. Historical prices are not a forecast.
Omda AS’s quoted price sits in the upper half of its reported 52-week range, 10.51% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
BEHIND THE RESULTS
Omda AS’s next earnings report is currently expected on Nov 18, 2026, with estimated earnings per share of NOK 1.07. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Omda AS’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Founded in 1999 and headquartered in Oslo, Norway, Omda AS delivers specialized software solutions to the healthcare and emergency response sectors across Norway, Sweden, Denmark, Finland, and internationally. Its software suite encompasses sophisticated laboratory information management systems, including Omda ProSang for managing blood, cell, and tissue data, as well as dedicated medical medication software like Omda Cytodose, designed for oncology treatment management. The company also offers a broad array of connected healthcare solutions. These include Omda Cardio for ECG and diagnostic archiving, mobile clinical imaging through Omda CIMA, web-based medical imaging tools such as Omda Media, and comprehensive image management and workflow solutions like Omda Medimaker and Omda Picsara. The connected healthcare portfolio also extends to Omda Arcidis, an integrated teleradiology system; Omda Helsemail, enabling secure patient data transfer; Omda Plutus for audit and workflow monitoring; Omda S7, a secure e-care communication platform; and Omda XDS for efficient patient data storage and management. Within the advanced assisted reproductive technology (ART) and maternity sectors, Omda delivers specialized data solutions. These include Omda Fertsoft for ART clinics, Omda iPana Hospital for digital maternity management, Omda iPana Maternity, a cloud-based platform supporting women's maternal care, and Omda Partus for comprehensive maternity sector data management. Furthermore, its health analytics offerings, such as Omda Compos for medical data management and Omda MedSciNet, facilitate the collection, analysis, and overall governance of medical data. Moreover, Omda provides crucial support to emergency organizations with robust solutions. Omda Optima enables digital simulations for testing resource distribution and operational strategies. This is complemented by Omda CoordCom, an integrated emergency response platform; Omda AMIS, a digital system for processing emergency calls and coordinating medical responses; and Omda Paratus, a dedicated emergency response system. Originally established as CSAM Health Group AS, the company adopted its current name, Omda AS, in September 2023.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:44 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 | May 14, 2025 | NOK 0.38+322.22% vs estimate | NOK 121.18M+3.57% vs estimate |
|---|
| Q4 2024 | Feb 26, 2025 | -NOK 1.57-728.0% vs estimate | NOK 115.69M+0.6% vs estimate |
|---|
| Q3 2024 | Nov 8, 2024 | NOK 1.01+241.91% vs estimate | NOK 103.00M-0.83% vs estimate |
|---|
Latest available per-share figures in NOK. The payout ratio compares dividends with earnings.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NOK 310.00+NOK 3.00 (+0.98%)
Medistim ASA’s quoted price sits in the upper half of its reported 52-week range, 1.9% below the high.
NOK 10.52-NOK 0.02 (-0.19%)
Circio Holding ASA’s quoted price sits in the upper half of its reported 52-week range, 32.99% below the high.
NOK 25.80+NOK 0.40 (+1.57%)
Nordhealth AS’s quoted price sits in the lower half of its reported 52-week range, 32.81% below the high.
NOK 21.10NOK 0.00 (0.0%)
Carasent ASA: Healthcare · Medical - Healthcare Information Services.
NOK 1.93-NOK 0.07 (-3.3%)
Nordic Nanovector ASA’s quoted price sits in the lower half of its reported 52-week range, 42.19% below the high.
NOK 6.93NOK 0.00 (0.0%)
Aqua Bio Technology ASA’s quoted price sits in the lower half of its reported 52-week range, 45.0% below the high.
NOK 0.59NOK 0.00 (0.0%)
Targovax ASA’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
NOK 2.05NOK 0.00 (0.0%)
Ultimovacs ASA’s quoted price sits in the lower half of its reported 52-week range, 85.04% below the high.
